Congress sets sights on pharma legislation

Ben Remaly

30 April 2021

Representative David Cicilline

A bipartisan group of lawmakers introduced a bundle of bills on Thursday designed to empower the Federal Trade Commission to stop branded pharmaceutical companies from delaying market entry of generic competition.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Ben Remaly

View full biography

Author | Editor, GCR USA

[email protected]

Tipline

Take two: The Tipline for 30 November 2023
If at first you don’t succeed, merge, merge again. The Obama Administration thwarted insurance mergers involving Cigna and Humana but it seems the companies want to pick another fight with the Department of Justice. The Wall Street Journal reported yesterday that the insurers are in talks to combine, in what would be the largest merger of the year, with both companies already trying to sell off competing assets.
Lights, in camera, action: The Tipline for 29 November 2023
Bayewatch: The Tipline for 28 November 2023

Congress sets sights on pharma legislation

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Already have access? Login below

Related Topics

Ben Remaly